Results 181 to 190 of about 1,441,749 (314)

Tailored management of chronic bacterial prostatitis with sequential fluoroquinolones and adverse effect mitigation strategies: A case report. [PDF]

IDCases
Nguyen TD.
europepmc   +1 more source

Improvements in Health‐Related Quality of Life With Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial

Arthritis Care &Research, EarlyView.
Objective Although treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL ...
Austin Barry, Bryant R. England, Harlan Sayles, Lindsay N. Helget, Maria Androsenko, Hongsheng Wu, Kaleb Michaud, Bridget Kramer, Jeff A. Newcomb, Mary T. Brophy, Anne Davis‐Karim, Ryan Ferguson, Michael H. Pillinger, Tuhina Neogi, Paul M. Palevsky, James R. O'Dell, Ted R. Mikuls   +16 more
wiley   +1 more source

The manicogenic properties of clozapine: a rare but serious potential adverse effect. [PDF]

J Psychiatry Neurosci
Cholette-Tétrault S, Bakhshi M, Traicu A, Joober R.   +3 more
europepmc   +1 more source

Localized Argyria Caused by Metallic Silver Aortic Grafts: A Unique Adverse Effect [PDF]

, 2013
P. Berger, J.B. Ricco, P. Liqui Lung, F.L. Moll   +3 more
openalex   +1 more source

Serum Uric Acid Levels in Older Adults: Associations With Clinical Outcomes and Implications for Reference Intervals in Those Aged 70 Years and Over

Arthritis Care &Research, EarlyView.
Objective Reports have linked both high and low serum uric acid (SUA) levels to adverse health outcomes. This study aimed to establish a reference interval for SUA in older adults and assessed its association with clinically relevant outcomes in relatively healthy, community‐dwelling individuals aged ≥70 years old.
Amanda J. Rickard, Cammie Tran, Hans G. Schneider, Flavia M. Cicuttini, Anita E. Wluka, Ego Seeman, Johannes T. Neumann, Md Nazmul Karim, Zhen Zhou, Sultana Monira Hussain, David P. Q. Clark, Daniel Clayton‐Chubb, Andrew M. Tonkin, Lawrence J. Beilin, Robyn L. Woods, John J. McNeil   +15 more
wiley   +1 more source

Toxic Shock Syndrome: A Rare but Dangerous Adverse Effect of Anabolic Steroid Injection. [PDF]

Clin Case Rep
Van der Borght E, Demuynck T, Keuleers L, Peetermans M, Vanbrabant P.   +4 more
europepmc   +1 more source

Chitosan Mitigated the Adverse Effect of Cd by Regulating Antioxidant Activities, Hormones, and Organic Acids Contents in Pepper (Capsicum Annum L.)

Melek Ekinci, Mostafakamal Shams, Metin Turan, Sümeyra Uçar, Esra Yaprak, Esra Arslan Yuksel, Murat Aydın, Emre İlhan, Güleray Ağar, Sezai Erċışlı, Ertan Yıldırım   +10 more
openalex   +1 more source

A link to better care: The effect of remote monitoring on long-term adverse cardiac events in a propensity score-matched cohort

, 2017
Guilherme Portugal, Pedro Silva Cunha, Bruno Valente, Joana Feliciano, Ana Lousinha, Sandra Alves, Manuel Braz, Ricardo Pimenta, Ana Sofia Delgado, Mário Oliveira, Rui Cruz Ferreira   +10 more
openalex   +1 more source

Cost‐Effectiveness of Low‐Dose Colchicine Prophylaxis When Starting Allopurinol Using the “Start‐Low Go‐Slow” Approach for Gout: Evidence From a Noninferiority Randomized Double‐Blind Placebo‐Controlled Trial

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to investigate the cost‐effectiveness of low‐dose colchicine prophylaxis for preventing gout flares when starting allopurinol using the “start‐low go‐slow” approach. Methods Participants with gout, fulfilling the American College of Rheumatology recommendations for starting urate‐lowering therapy and with serum urate
Yana Pryymachenko, Ross Wilson, Nicola Dalbeth, J. Haxby Abbott, Lisa Stamp   +4 more
wiley   +1 more source

Respiratory Alkalosis as an Adverse Effect of Safinamide? [PDF]

Eur J Case Rep Intern Med
Freitas F, Rosa B, Pinto Silva C, Marques C, Mota J, Lemos Costa C, Oliveira C.   +6 more
europepmc   +1 more source